Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Search Results for "Sk Biopharmaceuticals Korea"

17:37 EDT 17th April 2014 | BioPortfolio

Original Source: SK Biopharmaceuticals

SK Biopharmaceuticals, a research and development company specializing in the discovery of small molecule drug candidates and their development from drug target through commercialization will remain in their headquarters in Fairfield, New Jersey. SK Energy & Chemicals, which manufactures and develops fine chemicals, pharmaceutical intermediates, and API's, will remain in their Fair Lawn, New Jersey offices. SK USA is the US headquarters for SK Group, Korea's third largest conglomerate. SK USA develops new...

Matching Channels

CaptureSelect

BAC’s CaptureSelect products are affinity ligands and affinity resins created by a proprietary technology based on Camelid-derived single domain antibody fragments for the purification of biop...

Boehringer Ingelheim

Boehringer Ingelheim is a global pharmaceutical company with annual sales of over $16 billion, making it the 10th largest pharmaceutical company in the world based on sales.  With bases in 47 c...

BioPortfolio Twitter Accounts

BioPortfolio has created approx 150 Twitter accounts with currently (June 2013 - 25,000 Twitter Followers) to support our users interest in keeping upto date on the latest news, research papers, rep...

Matching News

Keryx Biopharmaceuticals, Inc.: GlobeNewswire Press Release: Keryx Biopharmaceuticals, Inc.

Keryx Biopharmaceuticals Announces Zerenex(TM) (Ferric Citrate Coordination Complex) Phase 2 Results in Non-Dialysis Dependent Chronic Kidney Disease Selected as a Late Breaking Oral Presentation a...

Keryx Biopharmaceuticals, Inc.: Keryx Biopharmaceuticals Strengthens Leadership Team With Key Additions in Sales, Corporate Development and Legal

NEW YORK, 2014-04-15 14:30 CEST (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX), a biopharmaceutical company focused on the acquisition, development and commercialization of pharma...

Agilent Supports Inaugural Singapore-South Korea Symposium on Glycomics

The Symposium aims to be a platform for scientists and researchers from both nations to work toward developing biomarkers for diseases, biopharmaceuticals and therapeutic antibody products through gly...

Keryx Biopharmaceuticals, Inc.: Keryx Biopharmaceuticals Announces the Appointment of Abraham Ceesay as Vice President of Marketing

Proven Global Renal Marketing Expert Joins Commercial Team NEW YORK, 2014-02-18 14:30 CET (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX), a biopharmaceutical company focused on th...

Keryx Biopharmaceuticals, Inc.: Keryx Biopharmaceuticals' Zerenex(TM) Data Selected for Poster Presentation at the AMCP's 26th Annual Meeting and Expo

Poster Highlights Potential Pharmacoeconomic Benefit for Managed Care Organizations NEW YORK, 2014-03-17 13:30 CET (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) today announced t...

Keryx Biopharmaceuticals, Inc.: Keryx Biopharmaceuticals Announces Submission of a Marketing Authorization Application for Zerenex(TM) to the European Medicines Agency

NEW YORK, 2014-03-10 13:30 CET (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) (the "Company") today announced it has submitted a Marketing Authorization Application ("MAA") to the...

Korea, Switzerland Ink MOU To Combine Talents In Pharma, Medical Devices

In a bid to bolster their respective health care industries, South Korea and Switzerland signed an MOU to cooperate on life sciences investments by combining Switzerland’s knowhow in precision machi...

Korea’s Health Ministry To Discontinue Controversial Pricing Policy

Amid strong opposition from within and outside Korea from pharma groups, Korea’s health ministry said it will discontinue its market-based actual transaction price system.

Matching PubMed Articles

Placental Transfer of Fc-Containing Biopharmaceuticals across Species, an Industry Survey Analysis.

Understanding species differences in placental transfer of Fc-containing biopharmaceuticals (particularly monoclonal antibodies) will improve human risk extrapolation from nonclinical embryo-fetal dev...

Contributions to the foliicolous lichens flora of South Korea.

South Korea is covered primarily by temperate vegetation; therefore, foliicolous lichens may not be expected to play an important role in its lichen flora. However, this study describes four foliicolo...

The Drug Resistance Profile of Mycobacterium abscessus Group Strains from Korea.

Bacteria of the Mycobacterium abscessus group are the second most common pathogens responsible for lung disease caused by nontuberculous mycobacteria in Korea. There is still a lack of studies investi...

Characteristics of Acromegaly in Korea with a Literature Review.

Acromegaly is a slowly progressive disease caused by excessive growth hormone (GH), which is related to a GH secreting pituitary tumor in most cases. Herein, we describe the epidemiology, clinical cha...

Genetically Modified T Cells for the Treatment of Malignant Disease.

The broaden application of adoptive T-cell transfer has been constrained by the technical abilities to isolate and expand antigen-specific T cells potent to selectively kill tumor cells. With the rece...

Search Whole site using Google

Loading
Search BioPortfolio:
Advertisement
Advertisement
Advertisement Advertisement